Clinical Natural Language Processing (NLP)

Learn more about what LynxCare stands for: from a cloud-agnostic solution and quality assurance to fostering research and network opportunities

CB Insights has released its “Digital Health 150” 2022 list, ranking LynxCare among the 150 most promising digital health startups in the world.

LynxCare announced it has appointed Alexander Rombaut as Chief Strategy Officer. Alexander will be leading the company’s internal operations, global strategy and execution of the company’s international expansion plans.

Real-World Evidence (RWE) has the power to change lives. It can allow for new treatments to come to market faster, but most importantly it provides valuable insights on how they perform where it really counts: real life. To harness the full potential of RWE for treatment optimization and research, we need to unlock the most critical data source: hospital data.

Today, we’re excited to announce the next big step in our journey: the completion of a €20M Series A investment round.

Illustrating LynxCare’s commitment to open-source common data models, the European Health Data and Evidence Network (EHDEN) has awarded LynxCare the certificate of EHDEN SME partner.

Illustrating LynxCare’s commitment to providing an effective and secure AI-powered clinical data platform for hospitals, LynxCare has received ISO 27001 certification for its overall security management.

Healthcare is one of, if not the, most important and impactful sectors to society. It is also one of the most rich in data, generated from care providers, clinical trials, research and more. However, this same magnitude and variety of data makes it difficult for providers to effectively utilize it for improved patient outcomes.

New technologies such as data mining, cloud computing, etc. must be used to uncover live-saving insights into this plethora of data. The question is: Can hospitals use these novel techniques to analyze this data? And is the GDPR an obstacle in this process?